Is this the first time a confirmation on the science has not stimulated the market. Mr market must really believe in the science and the quality of SI's announcements.
Perhaps the market is waiting for proof that FDA is not all talk and no action in regards to fast track.
Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-5
Add to My Watchlist
What is My Watchlist?
